Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ

Srisathiyanarayanan Dharmaiah1, Lakshman Bindu1, Timothy H Tran1

  • 1NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701.

Insights

Structural studies reveal how Phosphodiesterase-δ (PDEδ) binds to farnesylated-methylated KRAS4b, crucial for KRAS signaling. This interaction, driven by KRAS4b

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biochemistry

Background:

  • KRAS4b post-translational modifications, farnesylation and carboxymethylation, are critical for plasma membrane localization and KRAS-mediated signaling.
  • Phosphodiesterase-δ (PDEδ) is a key protein involved in targeting prenylated KRAS4b to cellular membranes.

Purpose of the Study:

  • To elucidate the structural basis of the interaction between human farnesylated-methylated KRAS4b and PDEδ.
  • To identify structural features that dictate PDEδ binding specificity to prenylated proteins.

Main Methods:

  • X-ray crystallography to solve structures of KRAS4b-PDEδ complexes in two crystal forms.
  • Sequence analysis to identify conserved binding motifs.
  • Comparative structural analysis of PDEδ complexes with various prenylated proteins.

Main Results:

  • The structures reveal that KRAS4b binds PDEδ via its C-terminal amino acids and the farnesylated/methylated C185 residue, which fits into PDEδ's hydrophobic pocket.
  • A 5-amino acid motif (Lys-Ser-Lys-Thr-Lys) in KRAS4b is identified as potentially mediating PDEδ binding to both farnesylated and geranylgeranylated forms.
  • A larger protein-protein interaction interface in the KRAS4b-PDEδ complex compared to other PDEδ complexes was observed.

Conclusions:

  • The KRAS4b-PDEδ complex structure provides detailed insights into the molecular interactions governing KRAS4b membrane targeting.
  • The identified binding motif and interaction interface offer potential targets for developing specific inhibitors of KRAS-PDEδ interaction.
  • Understanding these interactions can help explain differential binding of PDEδ to various prenylated proteins, including why some, like KRAS4a, do not bind.

Related Concept Videos

Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
6.9K
Lipids as Anchors01:32

Lipids as Anchors

In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
7.8K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
6.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
7.3K